keyword
https://read.qxmd.com/read/38605694/postoperative-anticoagulation-management-using-subcutaneous-unfractionated-heparin-for-a-patient-with-nonbacterial-thrombotic-endocarditis-a-case-report
#21
Hiroki Mine, Kosuke Saku, Kazuyoshi Takagi, Shoichiro Nohara, Shinichi Hiromatsu, Yoshihiro Fukumoto, Eiki Tayama
Nonbacterial thrombotic endocarditis (NBTE) presents nonbacterial vegetation on cardiac valves. NBTE requires appropriate anticoagulant therapy to prevent recurrence after surgery. However, there has not yet been established evidence for anticoagulant therapy in NBTE, and low molecular weight heparin is not approved in Japan. We present a case of NBTE that was successfully managed with anticoagulant therapy using subcutaneous unfractionated heparin. A 59-year-old woman was diagnosed with NBTE on the mitral and tricuspid valve associated with breast cancer, underwent valve replacement...
April 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38602066/low-molecular-weight-heparin-salvage-in-pedicled-flap-reconstruction-in-head-and-neck-a-prospective-cohort-study
#22
JOURNAL ARTICLE
Smriti Panda, Vimmi Gautam, Sandipta Mitra, Chirom Amit Singh, Suresh M, Akshara Palreddy, Yuvanesh K, Abhilash Konkimalla, Dheeraj K, Debadeep Bagchi, Sarath Raveendran, Kapil Sikka, Rajeev Kumar, Anup Singh, Alok Thakar
No abstract text is available yet for this article.
April 11, 2024: Journal of Laryngology and Otology
https://read.qxmd.com/read/38601129/characterization-of-the-benefits-and-risks-of-therapeutic-anticoagulation-in-patients-admitted-with-severe-covid-19-critac
#23
JOURNAL ARTICLE
Alison Jinn, Michael Kammermayer, Vincent H Mabasa, Tracy Liu, Tarnvir Sonia Paul, Nam Phan
BACKGROUND: Severe COVID-19 is associated with increased rates of thrombotic complications. Recent provincial recommendations in British Columbia have suggested providing thromboprophylaxis with therapeutic anticoagulation for hospital inpatients with severe COVID-19 who do not have a high risk of bleeding. OBJECTIVES: To characterize the rates of major bleeding, thrombotic events, complications from COVID-19, and adverse effects among patients with severe COVID-19 treated with therapeutic anticoagulation...
2024: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/38596416/evaluation-of-the-safety-and-efficacy-of-enoxaparin-once-daily-versus-twice-daily-dosing-for-prophylaxis-in-pediatric-patients
#24
JOURNAL ARTICLE
Danielle Morgan, Jinjoo Kang, Chana Levine, Suchitra Acharya
OBJECTIVES: Enoxaparin for the prevention of venous thromboembolism (VTE) in pediatric patients is -typically dosed twice a day. The use of once-daily dosing like that used in adult patients is limited because of a lack of safety and efficacy data. The aim of this study was to evaluate the safety and efficacy of -once-daily versus twice-daily dosing of enoxaparin for pediatric VTE prophylaxis based on incidence of thrombotic and bleeding events. METHODS: This was a 3-year retrospective chart review of enoxaparin received for VTE prophylaxis at -Cohen Children's Medical Center, New Hyde Park, NY...
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38592277/thrombosis-and-bleeding-risk-scores-are-strongly-associated-with-mortality-in-hospitalized-patients-with-covid-19-a-multicenter-cohort-study
#25
JOURNAL ARTICLE
Kunapa Iam-Arunthai, Supat Chamnanchanunt, Pravinwan Thungthong, Poj Intalapaporn, Chajchawan Nakhahes, Tawatchai Suwanban, Ponlapat Rojnuckarin
Background: Internationally established guidelines mention pharmacological prophylaxis for all hospitalized COVID-19 patients. However, there are concerns regarding the efficacy and safety of anticoagulants. This study investigated the associations between thrombosis/bleeding risk scores and clinical outcomes. Methods: We conducted a retrospective review of adult patients admitted to two hospitals between 2021 and 2022. We analyzed clinical data, laboratory results, low molecular weight heparin (LMWH) use, thrombosis, bleeding, and 30-day survival...
March 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38586812/may-thurner-syndrome-the-worst-case-scenario
#26
Marta Costa, Gonçalo Ferreira, Dora Gomes, Catarina Oliveira, Nelson Domingues
May-Thurner syndrome (MTS) is caused by compression of the left common iliac vein by the right common iliac artery against the spinal column. It can range from asymptomatic or present with subtle and unspecific signs and symptoms and rarely exhibit severe complications such as pulmonary embolism (PE). The diagnosis is confirmed by typical imaging findings. Treatment may include conservative measures, anticoagulation, endovascular or even surgical options. We report the case of a 20-year-old female who presented with cardiac arrest caused by an acute massive PE...
March 2024: Curēus
https://read.qxmd.com/read/38583546/a-systematic-review-and-meta-analysis-of-the-effectiveness-of-primary-thromboprophylaxis-in-acute-lymphoblastic-leukemia-during-early-phase-therapy-including-asparaginase-or-its-prolonged-form
#27
REVIEW
Zhongbo Hu, Yogindra Persaud, Sanjay Ahuja
Asparaginase is essential in the initial management of acute lymphoblastic leukemia (ALL) but frequently leads to venous thromboembolism (VTE). Using anticoagulants for primary VTE prevention has been studied with no consensus. We conducted a systematic literature search in PubMed, Scopus, and Web of science and performed random-effect meta-analysis using Mantel-Haenszel method in RevMan 5.4 to analyze primary pharmacological thromboprophylaxis during asparaginase treatment in early-phase (induction, consolidation, or intensification phase) therapy in patients with ALL with all ages and followed with subgroup analysis by age...
April 5, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38583310/acute-pulmonary-embolism-in-cancer-patients-admitted-to-intensive-care-unit-impact-of-anticoagulant-treatment-on-90-day-mortality-and-risk-factors-results-of-a-multicentre-retrospective-study
#28
JOURNAL ARTICLE
Djamel Mokart, Edouard Serre, Fabrice Bruneel, Achille Kouatchet, Virginie Lemiale, Laurent Chow-Chine, Marion Faucher, Antoine Sannini, Sandrine Valade, Magali Bisbal, Frederic Gonzalez, Luca Servan, Michaël Darmon, Elie Azoulay
BACKGROUND: Acute pulmonary embolism (PE) is a life-threatening situation in cancer patients. In this situation, anticoagulant therapy is complex to administer due to the risk of bleeding. Only few studies have been conducted when these patients are admitted to the intensive care unit (ICU). The aim of this study was to assess the association between anticoagulation strategies as well as other factors with 90-day mortality in patients with cancer and PE admitted to ICU. Major bleeding was also evaluated according to the type of anticoagulation...
March 31, 2024: Thrombosis Research
https://read.qxmd.com/read/38576748/low-molecular-weight-heparin-and-preeclampsia-does-the-sword-cut-both-ways-three-case-reports-and-review-of-literature
#29
Dan Shan, Tao Li, Xi Tan, Ya-Yi Hu
BACKGROUND: Low-molecular-weight heparins (LMWH) are the most commonly used anticoagulants during pregnancy. It is considered to be the drug of choice due to its safety in not crossing placenta. Considering the beneficial effect in the improvement of microcirculation, prophylactic application of LMWH in patients with preeclampsia became a trend. However, the bleeding risk related with LMWH in preeclampsia patients has seldomly been evaluated. This current study aimed to identify the potential risks regarding LMWH application in patients with preeclampsia...
March 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38570020/combination-anticoagulation-strategy-in-pregnancy-with-mechanical-valves-the-kybele-study
#30
JOURNAL ARTICLE
Mehmet Özkan, Ahmet Güner, Sabahattin Gündüz, Gazi Yıldız, Ayşe İnci Yıldırım, Macit Kalçık, Mahmut Yesin, Emrah Bayam, Semih Kalkan, Mustafa Ozan Gürsoy, Alev Kılıçgedik, Zübeyde Bayram, Münevver Sarı, Mehmet Aytürk, Süleyman Karakoyun, Mehmet Ali Astarcıoğlu, Elif Cansu Gündoğdu, Asuman Biçer, Emre Gürcü, Tuncer Koçak, Recep Demirbağ
BACKGROUND: Optimal first-trimester anticoagulation is still challenging in pregnant women with mechanical heart valves (MHVs) requiring high-dose warfarin.This multicenter prospective study aims to determine the optimal anticoagulation regimens for pregnant patients with MHVs. METHODS: All women were allocated to one of three treatment options during first trimester including lone low-molecular-weight heparin (LMWH), combination of LMWH+2.5 mg warfarin, and LMWH+4 mg warfarin...
April 1, 2024: American Heart Journal
https://read.qxmd.com/read/38567682/what-is-a-low-low-molecular-weight-heparin-dose
#31
JOURNAL ARTICLE
Anne Godier, Juan V Llau, Raquel Ferrandis, Sibylle Langenecker
No abstract text is available yet for this article.
May 1, 2024: European Journal of Anaesthesiology
https://read.qxmd.com/read/38567581/clinical-study-of-tirofiban-compared-to-low-molecular-weight-heparin-in-the-antithrombotic-treatment-of-progressive-pontine-infarction
#32
RANDOMIZED CONTROLLED TRIAL
Q Zhou, L-E Xu, L-L Lin, X-R Huang, W-Z Chi, J Lin, P Lin
OBJECTIVE: To investigate the efficacy and safety of tirofiban and low molecular weight heparin (LMWH) in the treatment of patients undergoing acute progressive pontine infarction. PATIENTS AND METHODS: Patients with acute progressive pontine infarction who were hospitalized in the Neurology Department from June 2021 to June 2023 were included in the study and randomly divided into two groups, namely the experimental group (tirofiban group) and the control group (LMWH group)...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38567103/post-partum-cerebral-venous-sinus-thrombosis-a-case-report
#33
Shruti Jain, Mehak Bhushan, Vandana Talwar
INTRODUCTION: Cerebral venous sinus thrombosis (CVST) is a rare and life-threatening condition that may be encountered during pregnancy and puerperium. The diagnosis of CVST is a challenge because of its varied presentation. CASE REPORT: A 28-year-old woman presented with headache, projectile vomiting, and generalized tonic-clonic seizures 10 days after delivery by cesarean section. She had an uneventful antenatal period of 38 weeks of gestation. High clinical suspicion and the availability of magnetic resonance venography helped in making a diagnosis of CVST...
2024: Qatar Medical Journal
https://read.qxmd.com/read/38564037/retro-pancreatic-pull-through-reconstruction-of-the-hypoplastic-portal-vein-using-the-autologous-mesosystemic-shunt-vessel-in-adult-living-donor-liver-transplantation-a-case-report
#34
JOURNAL ARTICLE
Shinsuke Sugenoya, Atsuyoshi Mita, Akira Shimizu, Yasunari Ohno, Koji Kubota, Yuichi Masuda, Tsuyoshi Notake, Yuji Soejima
BACKGROUND: In liver transplant patients with hypoplastic portal vein (PV), when the narrowed segment is extended too deep into the dorsal side of the pancreas, it is difficult and dangerous to reconstruct the interposition graft from the upper part of the pancreas. Herein, we present a case of PV reconstruction with the autologous mesosystemic shunt vessel from the caudal side of the pancreas in a situation where the narrowed PV was deep, and we discuss the technical details. CASE PRESENTATION: A 25-year-old woman presented with cholestatic liver cirrhosis due to biliary atresia after Kasai procedure...
April 2, 2024: Surgical Case Reports
https://read.qxmd.com/read/38558108/clinical-guidelines-for-prevention-and-treatment-of-cat-in-japan-and-other-countries
#35
REVIEW
Yoshinobu Seki
Cancer-associated thrombosis (CAT) is an important prognostic factor for an increasing number of cancer patients. Understanding of CAT among cancer care providers has grown in recent years, and guidelines for the prevention and treatment of CAT have been published in Japan and around the world. In this article, we introduce these major guidelines and discuss differences we identified between the Japanese guidelines and those of other countries, with a focus on problems and issues. Insurance coverage of low-molecular-weight heparin and indications for primary prevention with direct oral anticoagulants in particular require urgent consideration...
April 1, 2024: International Journal of Hematology
https://read.qxmd.com/read/38548714/anticoagulation-in-venous-thromboembolism-for-the-general-physician
#36
REVIEW
Katherine Stark, Abhinav Mathur, Mohammed M Khan
Venous thromboembolism (VTE) is frequently encountered across various specialties. The management of VTE has become more nuanced, requiring consideration of several factors when deciding on the choice and duration of anticoagulation. This evidence-based review article summarises the current practice and evidence behind anticoagulation in VTE, incorporating national and international guidelines. Factors influencing decision-making around the choice and duration of anticoagulation, along with special circumstances such as cancer and antiphospholipid syndrome, are discussed...
March 28, 2024: Journal of the Royal College of Physicians of Edinburgh
https://read.qxmd.com/read/38547694/the-incidence-of-venous-thromboembolism-after-curative-colon-cancer-surgery-within-an-enhanced-recovery-after-surgery-programme
#37
JOURNAL ARTICLE
Niklas Nygaard Baastrup, Astrid Kerstine Buch, Anders Kierkegaard Gundestrup, Anna Sofie Friis Olsen, Jakob Kleif, Issam Al-Najami, Ulrik Deding, Claus Anders Bertelsen
AIM: Based on three randomised controlled trials performed more than a decade ago, several national guidelines recommend prolonged venous thromboprophylaxis for 28 days following elective surgery for colon cancer. None of these studies were conducted within enhanced recovery after surgery setting. Newer studies indicate that prolonged prophylaxis might not be necessary with enhanced recovery after surgery. We aimed to provide further evidence to this unresolved discussion. METHOD: Retrospective study of patients undergoing elective surgery for colon cancer stage I-III with enhanced recovery after surgery in the Capital Region of Denmark from 2014 to 2017...
March 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38542049/venous-thromboembolism-management-throughout-the-covid-19-era-addressing-acute-and-long-term-challenges
#38
JOURNAL ARTICLE
Maddalena Alessandra Wu, Alba Taino, Pietro Facchinetti, Valentina Rossi, Diego Ruggiero, Silvia Berra, Giulia Blanda, Nicola Flor, Chiara Cogliati, Riccardo Colombo
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data exist on VTE challenges in the acute setting throughout a dynamic long-term follow-up of COVID-19 patients compared to non-COVID-19 patients. The aim of the study was to investigate acute and long-term management and complications in VTE patients with and without COVID-19. Methods: A prospective, observational, single-center cohort study on VTE patients followed from the acute care stage until 24 months post-diagnosis...
March 21, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38541634/comparative-analysis-of-antithrombotic-therapy-outcomes-in-mild-traumatic-brain-injury-patients-a-focus-on-bleeding-risk-and-hospital-stay-duration
#39
JOURNAL ARTICLE
Antonio Desai, Dana Shiffer, Mauro Giordano, Alice Giotta Lucifero, Elena Generali, Francesco Reggiani, Marta Calatroni, Gabriele Savioli, Sabino Luzzi, Antonio Voza
BACKGROUND: Traumatic brain injury (TBI) in the elderly is a noteworthy pathology due to the exponential increase in population age, and the effects of antiplatelet and anticoagulation on patients' outcomes are still a matter of dispute. The aim of the present study was to evaluate the impact of various antithrombotic agents on patients with mild TBI, focusing on the risk of intracranial bleeding (ICH) and length of hospitalization (LOS). METHODS: A retrospective analysis was conducted, including patients with a diagnosis of TBI admitted to the Emergency Department between 2021 and 2022...
February 27, 2024: Life
https://read.qxmd.com/read/38540218/insulin-and-metformin-administration-unravelling-the-multifaceted-association-with-mortality-across-various-clinical-settings-considering-type-2-diabetes-mellitus-and-covid-19
#40
JOURNAL ARTICLE
Łukasz Lewandowski, Agnieszka Bronowicka-Szydełko, Maciej Rabczyński, Dorota Bednarska-Chabowska, Joanna Adamiec-Mroczek, Adrian Doroszko, Małgorzata Trocha, Krzysztof Kujawa, Agnieszka Matera-Witkiewicz, Edwin Kuźnik, Paweł Lubieniecki, Marcin Madziarski, Janusz Sokołowski, Ewa A Jankowska, Katarzyna Madziarska
Due to the molecular mechanisms of action of antidiabetic drugs, they are considered to be effective in the treatment of both COVID-19 and the post-COVID-19 syndromes. The aim of this study was to determine the effect of administering insulin and metformin on the mortality of patients with type 2 diabetes (T2DM) with symptomatic COVID-19 with the use of logistic regression models. The association between death and insulin and metformin was weak and could not be included in the multivariate model. However, the interaction of both drugs with other factors, including remdesivir and low-molecular-weight heparin (metformin), age and hsCRP (insulin), modulated the odds of death...
March 7, 2024: Biomedicines
keyword
keyword
102506
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.